The Clinical Laboratory Improvement Amendments (CLIA) of 1988 require individuals (pathologists and cytotechnologists) who screen or interpret gynecological cytology specimens to be annually enrolled in a Centers for Medicare & Medicaid Services (CMS)-approved cytology proficiency testing (PT) program. CMS has approved two cytology PT programs for testing in 2005.
Document Type: Research Article
Publication date: May 1, 2005
More about this publication?
The Joint Commission Perspectives gives you the what, when, and how to help your organization stay up-to-date on The Joint Commission initiatives and maintain continuous standards compliance. Perspectives is your primary source of timely, readable, and useful information about changes to Joint Commission standards and requirements, the survey/review process, the scoring and decision process, patient safety initiatives, ORYX® performance measurement requirements, and much more.
Please note that this title is published in 'magazine' style. Many sections begin on one page and finish on another page later in the issue. The number of pages shown on the table of contents is not necessarily the correct number of pages that will download.